• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类前列腺癌中13号染色体长臂上等位基因缺失

Allelic loss on chromosome 13q in human prostate carcinoma.

作者信息

Melamed J, Einhorn J M, Ittmann M M

机构信息

Department of Pathology, New York University School of Medicine, Kaplan Cancer Center, New York, New York 10010, USA.

出版信息

Clin Cancer Res. 1997 Oct;3(10):1867-72.

PMID:9815575
Abstract

To clarify the role in prostate tumorigenesis played by loss of the three known or putative tumor suppressor loci on the centromeric portion of chromosome 13q, we examined 80 clinically localized and 15 advanced prostate carcinomas for allelic loss at microsatellite markers mapped to this region, including markers tightly linked to the BRCA-2, retinoblastoma (Rb), and DBM (deleted in B-cell malignancy) loci. Among the 80 clinically localized cases, 24 showed allelic loss at one or more 13q loci. In all cases with loss, the Rb and/or DBM loci were lost. No cases were found with loss of Rb without loss of DBM or loss of DBM without loss of Rb, implying a role for both the Rb and DBM loci in clinically localized prostate cancer. Loss of the BRCA-2 locus was less common (4 of 55 informative cases) and was always associated with loss of Rb and/or DBM loci. Thus, the BRCA-2 locus does not appear to play as important a role in clinically localized prostate cancer as the Rb and/or DBM loci. Allelic loss on 13q was extremely common in the clinically advanced cases; it was present in 14 of the 15 cases. The rate of allelic loss at each of the three tumor suppressor loci was increased significantly in the advanced cases (P < 0.01, Fisher's exact test). Thus, loss of heterozygosity on 13q is very common in prostate cancer and occurs at all three known or putative tumor suppressor loci on the centromeric portion of chromosome 13q.

摘要

为了阐明位于13号染色体长臂着丝粒部分的三个已知或假定的肿瘤抑制基因座缺失在前列腺肿瘤发生中的作用,我们检测了80例临床局限性前列腺癌和15例晚期前列腺癌,以观察定位于该区域的微卫星标记的等位基因缺失情况,这些标记包括与BRCA-2、视网膜母细胞瘤(Rb)和DBM(B细胞恶性肿瘤中缺失)基因座紧密连锁的标记。在80例临床局限性病例中,24例在一个或多个13q基因座出现等位基因缺失。在所有出现缺失的病例中,Rb和/或DBM基因座均缺失。未发现Rb缺失而DBM未缺失或DBM缺失而Rb未缺失的病例,这表明Rb和DBM基因座在临床局限性前列腺癌中均起作用。BRCA-2基因座的缺失较少见(55例信息性病例中有4例),且总是与Rb和/或DBM基因座的缺失相关。因此,BRCA-2基因座在临床局限性前列腺癌中似乎不如Rb和/或DBM基因座起重要作用。13q上的等位基因缺失在临床晚期病例中极为常见;15例中有14例存在。在晚期病例中,三个肿瘤抑制基因座中每个基因座的等位基因缺失率均显著增加(P<0.01,Fisher精确检验)。因此,13q上的杂合性缺失在前列腺癌中非常普遍,且发生在13号染色体长臂着丝粒部分的所有三个已知或假定的肿瘤抑制基因座上。

相似文献

1
Allelic loss on chromosome 13q in human prostate carcinoma.人类前列腺癌中13号染色体长臂上等位基因缺失
Clin Cancer Res. 1997 Oct;3(10):1867-72.
2
LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.对位于13号染色体13q13区域的假定肿瘤抑制基因C13所在区域进行杂合性缺失分析。
Anticancer Res. 2001 Jul-Aug;21(4A):2341-50.
3
Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.将一个假定的人类前列腺癌肿瘤抑制基因定位在染色体13q14.3上。
Oncogene. 1999 Dec 9;18(52):7576-83. doi: 10.1038/sj.onc.1203203.
4
Distinct regions of allelic loss on 13q in prostate cancer.前列腺癌中13号染色体长臂上等位基因缺失的不同区域。
Cancer Res. 1996 Mar 1;56(5):1142-5.
5
Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.淋巴结转移与食管鳞状细胞癌13q12 - 13染色体上等位基因缺失有关。
Cancer Res. 1999 Aug 1;59(15):3724-9.
6
Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.前列腺癌中13q14、13q21 - 22和13q33处等位基因缺失的三个不同区域。
Genes Chromosomes Cancer. 1999 Jun;25(2):108-14.
7
Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.限定假定的人类前列腺癌肿瘤抑制基因在18号染色体长臂上的位置。
Oncogene. 2001 Apr 26;20(18):2273-80. doi: 10.1038/sj.onc.1204310.
8
Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.
Genes Chromosomes Cancer. 1996 Dec;17(4):245-53. doi: 10.1002/(SICI)1098-2264(199612)17:4<245::AID-GCC6>3.0.CO;2-3.
9
Allelic loss on chromosome 10 in prostate adenocarcinoma.前列腺腺癌中10号染色体的等位基因缺失。
Cancer Res. 1996 May 1;56(9):2143-7.
10
Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.高级别前列腺上皮内瘤变以及临床意义不显著和显著的前列腺癌在13号染色体长臂的等位基因分型分析。
Prostate. 2006 Mar 1;66(4):405-12. doi: 10.1002/pros.20363.

引用本文的文献

1
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.侵袭性变异相关肿瘤抑制基因在前列腺癌各阶段新兴的预测和预后作用。
Int J Mol Sci. 2025 Jan 1;26(1):318. doi: 10.3390/ijms26010318.
2
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications.前列腺癌中失调激酶的作用:分子基础与治疗意义。
Endocr Relat Cancer. 2023 Jul 26;30(9). doi: 10.1530/ERC-23-0011. Print 2023 Sep 1.
3
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer.
BRCA2 缺陷型原发性和转移性前列腺癌的肿瘤突变图谱
NPJ Precis Oncol. 2022 Jun 17;6(1):39. doi: 10.1038/s41698-022-00284-6.
4
Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.小 RNA 诱导 INTS6 基因上调通过调控 β-连环蛋白信号抑制去势抵抗性前列腺癌细胞。
Cell Cycle. 2018;17(13):1602-1613. doi: 10.1080/15384101.2018.1475825. Epub 2018 Aug 2.
5
Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression.微小RNA在雄激素信号传导及前列腺癌进展中的意义
Cancers (Basel). 2017 Aug 7;9(8):102. doi: 10.3390/cancers9080102.
6
The roles of microRNAs in the progression of castration-resistant prostate cancer.微小RNA在去势抵抗性前列腺癌进展中的作用
J Hum Genet. 2017 Jan;62(1):25-31. doi: 10.1038/jhg.2016.69. Epub 2016 Jun 9.
7
AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.年龄/晚期糖基化终末产物受体/蛋白激酶B信号通路通过促进视网膜母细胞瘤蛋白磷酸化和降解来促进前列腺癌细胞增殖。
Am J Cancer Res. 2015 Apr 15;5(5):1741-50. eCollection 2015.
8
Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.嗅鞘蛋白 4 基因缺失与人前列腺癌的进展相关。
Am J Pathol. 2013 Oct;183(4):1329-38. doi: 10.1016/j.ajpath.2013.06.028.
9
Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.Skp2 过表达与人类前列腺癌中 BRCA2 蛋白的丢失有关。
Am J Pathol. 2011 May;178(5):2367-76. doi: 10.1016/j.ajpath.2011.01.050.
10
Genomic profiling of prostate cancers from African American men.非裔美国男性前列腺癌的基因组分析
Neoplasia. 2009 Mar;11(3):305-12. doi: 10.1593/neo.81530.